P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

May 2003

Features

Editor’s Memo

Editorial Board Spotlight: Mark J. Baumel, MD, MS

P&T welcomes Dr. Baumel, the newest addition to our editorial board.
Sonja Sherritze

Drug Safety Revisions: FDA Update

The author reviews new warnings and label changes for sirolimus (Rapamune®), pergolide mesylate (Permax®), and salmeterol xinafoate inhalation aerosol (Serevent®).
Marvin M. Goldenberg, PhD, RPh, MS

Physician Perspective

An Invaluable $4 Gift

A practicing physician relates the story of the best $4 he ever spent.
Thomas Marzili, MD

Cover Story

Evaluation of Beta Interferons for Multiple Sclerosis

The authors present an in-depth review of Rebif® for prevention of relapses in patients with MS.
Abby Guest, PharmD Candidate, and Richard Cramer, PharmD

Costs of Respiratory Syncytial Virus Infection at a Tertiary-Care Children’s Hospital

Determining the expenditures related to RSV infection requires diagnostic confirmation, a chart review, and an analysis of billing costs.
Ben Z. Katz, MD, Joseph Lo, MPH, and Mark Sorrentino, MD, MS

Highlights of the 52nd Scientific Session of The American College of Cardiology

Dr. Prescott reviews drug-coated stents, beta blockade, a thrombin inhibitor, a new statin, a lipid-lowering formulation, and other advances presented at the ACC meeting.
Lawrence M. Prescott, PhD

Reader Response

Response to "What’s Going to Happen to Brave Surgeons and Patients?”

Daniel McDevitt, MD, FACS

Departments

Editorial

Glossary of P&T Slang

Editor-in-Chief David Nash, MD, MBA, puts a new “spin” on some commonly used jargon in P&T committees.
David B. Nash, MD, MBA

Medication Errors

Medication Error-Prevention “Toolbox”

Matthew Grissinger discusses a set of “tools” for preventing medication errors.
Matthew Grissinger, RPh

Prescription Washington

“It’s the Hospitals, Stupid!”: Bar Code Proposal Relies on Hospitals to Buy Expensive Scanners

Stephen Barlas describes the new bar-code proposal for hospitals.
Stephen Barlas

Drug Forecast

Peginterferon alfa-2a: A New Agent for Hepatitis C Virus Infection

The authors review peg-interferon alfa-2a (Pegasys®) for the treatment of hepatitis C virus infection.
Tarrah Williams, PharmD Candidate, Marlon Honeywell, PharmD, Evans Branch III, PharmD, and Michael Thompson, BCNSP, PharmD

Drug News

New Drugs/Drug News

P&T presents the latest information about approvals, indication changes, industry updates, and news from the FDA